Diseases, Conditions, Syndromes

Barriers to uptake of hepatitis C medication

La Trobe University researchers have found that multiple barriers continue to prevent some people from accessing life-saving new hepatitis C treatment, including experiences of stigma within the health care system.

Health

Analysis finds government websites downplay PFAS health risks

State and federal public health agencies often understate the scientific evidence surrounding the toxicity of per- and polyfluoroalkyl substances (PFAS) in their public communications, according to an analysis published today ...

Medications

FDA approves Pfizer pill as first at-home COVID-19 treatment

(HealthDay)—The U.S. Food and Drug Administration on Wednesday approved the emergency use of the new Pfizer antiviral pill Paxlovid in people who are at high risk for severe COVID-19. It is the first approved treatment ...

Diseases, Conditions, Syndromes

Study on PFAs and fatty liver disease: Women more affected than men

Women are affected to a greater degree than men when exposed to PFAs, a group of highly fluorinated chemicals. A study from Örebro University shows how PFAs affect metabolism and lead to liver damage, so-called fatty liver ...

page 10 from 34